Form 4 Tracker
Alexandra Hughes-Wilson

Chief Patient Access and Commercial Planning · 1 filing · Latest: Feb 1, 2026

Mereo BioPharma Group plc
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MREO
Alexandra Hughes-WilsonSep 12, 2024
Proposed Sale
$4.66148,110$690.2K